MedPath

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Neuromuscular Disease

Completed
Conditions
Healthy
Neuromuscular Disease
Peripheral Nervous System Disease
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
1500
Registration Number
NCT00001201
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor

Completed
Conditions
Astrocytoma
Glioblastoma
Glioma
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
25
Registration Number
NCT00001148
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Transcranial Magnetic Stimulation for the Treatment of Phantom Pain

Phase 1
Completed
Conditions
Pain
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
20
Registration Number
NCT00001923
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Potential Risk Factors for Stroke

Phase 1
Completed
Conditions
Carotid Atherosclerosis
Cerebrovascular Accident
Diabetes Mellitus
Hypercholesterolemia
Hypertension
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
500
Registration Number
NCT00001368
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells

Phase 1
Completed
Conditions
Gaucher's Disease
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
120
Registration Number
NCT00001234
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Diagnosis and Natural History Study of Patients With Neurological Conditions

Completed
Conditions
Alzheimer's Disease
Dementia
Movement Disorder
Multiple System Atrophy
Parkinson's Disease
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
600
Registration Number
NCT00001549
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)

Phase 2
Completed
Conditions
Multiple Sclerosis
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
25
Registration Number
NCT00001781
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Monitoring Patients With Uncontrolled Epilepsy

Completed
Conditions
Epilepsy
Seizures
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
900
Registration Number
NCT00001149
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Study of "Post-Polio Syndrome"

Completed
Conditions
Poliomyelitis
Postpoliomyelitis Syndrome
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
360
Registration Number
NCT00001185
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Nefiracetam in the Treatment of Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
50
Registration Number
NCT00001933
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath